Lungteh Shipbuilding Co., Ltd. (TPE:6753)

Market Cap	11.65B
Revenue (ttm)	5.22B
Net Income (ttm)	619.50M
Shares Out	113.14M
EPS (ttm)	5.31
PE Ratio	19.41
Forward PE	n/a
Dividend	1.25 (1.25%)
Ex-Dividend Date	Aug 26, 2024

Volume	729,376
Average Volume	805,020
Open	102.50
Previous Close	103.00
Day's Range	100.00 - 103.00
52-Week Range	87.30 - 147.50
Beta	0.00
RSI	56.70
Earnings Date	Aug 12, 2025

About Marinus Pharmaceuticals

Lungteh Shipbuilding Co., Ltd. engages in the shipbuilding business. It offers naval vessels, patrol/interceptor/RIB boats, harbor service boats, passenger/ferry/crew boats, fire/rescue/surveillance boats, and hydrographic/research vessels, as well as SWATH vessels and boats. Lungteh Shipbuilding Co., Ltd. was founded in 1979 and is based in Yílán, Taiwan.

• Industry: Aerospace & Defense
• Sector: Industrials
• Founded: 1979
• Employees: 811
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6753

Financial Performance

In 2024, Lungteh Shipbuilding's revenue was 5.12 billion, an increase of 2.64% compared to the previous year's 4.99 billion. Earnings were 706.62 million, an increase of 22.89%.